Temi Oduozor
Plus aucun poste en cours
Profil
Temi Oduozor worked as a Controller at Anthera Pharmaceuticals, Inc. from 2011 to 2014, at Questcor Pharmaceuticals, Inc. from 2008 to 2011, and as the Controller, Chief Financial & Accounting Officer at Giga-tronics, Inc. from 2016 to 2018.
Oduozor obtained an undergraduate degree from The California State University.
Anciens postes connus de Temi Oduozor
Sociétés | Poste | Fin |
---|---|---|
GIGA-TRONICS INCORPORATED | Directeur Financier/CFO | 23/02/2018 |
ANTHERA PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/11/2014 |
QUESTCOR PHARMACEUTICALS INC | Comptroller/Controller/Auditor | 01/01/2011 |
Formation de Temi Oduozor
The California State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
GIGA-TRONICS INCORPORATED | Electronic Technology |
ANTHERA PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Questcor Pharmaceuticals, Inc.
Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |